Session Information
-
WCLC 2021
2022 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
P70 - Tumor Biology and Systems Biology: Basic and Translational Science - Omics Analysis of Lung Cancer
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Tumor Biology and Systems Biology: Basic and Translational Science
-
+
P70.01 - KRAS G12C Mutations Among NSCLC Patients Present With a High Intrerregional Variation, Indicating a Population Substructure
00:00 - 00:00 | Presenter: Andres Felipe Cardona Zorrilla
- Abstract
Loading... -
+
P70.02 - Clinicopathological and Genetic Ancestry Impact of TP53 Mutations in Brazilian Lung Adenocarcinoma Patients
00:00 - 00:00 | Presenter: Rodrigo de Oliveira Cavagna
- Abstract
Loading... -
+
P70.03 - Computational Omics Biology Model (CBM) Identifies Amplifications of Chromosome 6p to Predict Chemotherapy Resistance
00:00 - 00:00 | Presenter: Vamsidhar Velcheti
- Abstract
Loading... -
+
P70.04 - Results From a Patient Avatar Program Utilizing Murine Xenografts and Organoids After Neoadjuvant Therapy for Operable NSCLC
00:00 - 00:00 | Presenter: Caroline Huynh
- Abstract
Loading... -
+
P70.05 - Identification of Germline Mutations in Young Never Smokers With Lung Adenocarcinoma by Whole Exome Sequencing
00:00 - 00:00 | Presenter: Yang Zhang
- Abstract
Loading... -
+
P70.06 - m6A reader IGF2BP1 High Protein Expression level Indicates a Poor Recovery for Lung Adenocarcinoma Patients
00:00 - 00:00 | Presenter: Xuequan Wang
- Abstract
Loading... -
+
P70.07 - Examples of Population Kinetics (PopKin) Assessments of Progression-Free (PFS) and Overall Survival (OS)
00:00 - 00:00 | Presenter: DAVID James STEWART
- Abstract
Loading... -
+
P70.08 - Allelic Frequencies of Population Markers Correlate with KRAS G12C Prevalence: Considerations for Ancestries and Molecular Epidemiology
00:00 - 00:00 | Presenter: Andres Felipe Cardona Zorrilla
- Abstract
Loading... -
+
P70.09 - NOTCH1 Mutations in East Asian Patients With Non-Small-Cell Lung Cancer
00:00 - 00:00 | Presenter: Qian Wang
- Abstract
Loading... -
+
P70.10 - Prevalence of KRAS and Concomitant Mutations in Advanced Lung Adenocarcinoma Patients
00:00 - 00:00 | Presenter: Carlos Gil Ferreira
- Abstract
Loading... -
+
P70.11 - Prevalence and Clinicopathological Characteristics of ARID1A Mutations in East Asian Patients With Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Qian Wang
- Abstract
Loading... -
+
P70.12 - NTRK Gene Fusion in Advanced Non Small Cell Lung Cancer at Pham Ngoc Thach Hospital - Viet Nam
00:00 - 00:00 | Presenter: NGUYEN SON LAM
- Abstract
Loading... -
+
P70.13 - Different Types of ERBB3 Mutations in Chinese Non-Small Cell Lung Cancer Patients
00:00 - 00:00 | Presenter: Qian Wang
- Abstract
Loading... -
+
P70.14 - PRKDC Mutations Recurrently Found in Non-Small Cell Lung Cancer in East Asian Patients
00:00 - 00:00 | Presenter: Qian Wang
- Abstract
Loading... -
+
P70.15 - Mutational Subtypes and Prognosis of East Asian Non-Small-Cell Lung Cancer Harboring NF2 Mutations
00:00 - 00:00 | Presenter: Qian Wang
- Abstract
Loading... -
+
P70.16 - Epidemiological Study of FGFR3 Mutations Among Non-Small Cell Lung Cancer Patients in China
00:00 - 00:00 | Presenter: Qian Wang
- Abstract
Loading... -
+
P70.17 - Molecular Characteristics and Prognosis TERT Mutations in East Asian Non-Small-Cell Lung Cancer Patients
00:00 - 00:00 | Presenter: Qian Wang
- Abstract
Loading... -
+
P70.18 - Distribution of GNAS Mutations in Chinese Patients With Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Qian Wang
- Abstract
Loading... -
+
P70.19 - Clinicopathologic Characteristics of Patients With LRP1B Mutations in Chinese Non-Small Cell Lung Cancer Patients
00:00 - 00:00 | Presenter: Qian Wang
- Abstract
Loading... -
+
P70.20 - Impact of KRAS and Co-occurring Mutations on NSCLC Master Regulator Network as Determined by Computational Omics Biology Model.
00:00 - 00:00 | Presenter: Michael Castro
- Abstract
Loading...
-
+
P71 - Tumor Biology and Systems Biology: Basic and Translational Science - Targeted Therapy of Lung Cancer
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Tumor Biology and Systems Biology: Basic and Translational Science
-
+
P71.01 - Targeting HSPA1A in ARID2-Deficient Lung Adenocarcinoma
00:00 - 00:00 | Presenter: Xue Wang
- Abstract
Loading... -
+
P71.02 - Molecular and Cellular Dynamics of Drug-Tolerant Persister (DTP) Cells During Osimertinib Therapy in EGFR Mutant Lung Adenocarcinoma
00:00 - 00:00 | Presenter: Masashi Mikubo
- Abstract
Loading... -
+
P71.03 - A New Combination Therapy for FGFR1-Amplified Lung Cancer
00:00 - 00:00 | Presenter: Zhang Yang
- Abstract
Loading... -
+
P71.04 - MiR-1243 Increases Radiosensitivity in EGFR-TKI Resistant Non-Small Cell Lung Cancer Cells
00:00 - 00:00 | Presenter: yasi xu
- Abstract
Loading... -
+
P71.05 - Use of a Multiscale NSCLC Tumor Heterogeneity Model to Predict Tumor Growth Under Gefitinib
00:00 - 00:00 | Presenter: Adèle L'Hostis
- Abstract
Loading...
-
+
IS04 - Industry Symposium Sponsored by Astrazeneca: Redefining the Treatment Journey in NSCLC with Immuno-oncology and EGFR-TKIs
- 05:15 - 06:15
- 9/09/2021
- Location: Industry Symposium Auditorium via Industry Hub
- Not for CME Credit
- Type: Industry Supported Symposium
- Track: N.A.
-
+
IS04.01 - Welcome and Introduction
05:15 - 05:20 | Presenter: Yi-Long Wu
- Abstract
No abstract available for this presentation
-
+
IS04.02 - Clinical Data with Immuno-oncology for Unresectable Stage III NSCLC
05:20 - 05:35 | Presenter: Suresh Senan
- Abstract
No abstract available for this presentation
-
+
IS04.03 - Translating the Clinical Benefits of EGFR-TKIs across EGFRm NSCLC
05:35 - 05:50 | Presenter: Zhijie Wang
- Abstract
No abstract available for this presentation
-
+
IS04.04 - Panel Discussion: Survivorship in NSCLC
05:50 - 06:15
- Abstract
No abstract available for this presentation
-
+
MTE03 - Meet the Expert - Mentorship for Established Thoracic Oncology Professionals
- 05:15 - 06:15
- 9/09/2021
- Location: IASLC Booth via Industry Hub and Exhibit Hall
- Not for CME Credit
- Type: Meet the Expert Sessions
- Track: N.A.
- Moderators:Jamal Khader
-
+
MTE03.01 - Mentorship for Established Thoracic Oncology Professionals
05:15 - 06:15 | Presenter: Nan Wu
- Abstract
No abstract available for this presentation
-
+
MTE04 - Meet the Expert - Thoracic Cancers Research and Resource Disparities among Geographic Regions
- 05:15 - 06:15
- 9/09/2021
- Location: IASLC Booth via Industry Hub and Exhibit Hall
- Not for CME Credit
- Type: Meet the Expert Sessions
- Track: N.A.
- Moderators:Laura Mezquita
-
+
MTE04.01 - Thoracic Cancers Research and Resource Disparities among Geographic Regions
05:15 - 06:15 | Presenter: David Harpole
- Abstract
No abstract available for this presentation
-
+
PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)
- 06:30 - 08:00
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Plenary
- Track: N.A.
- Moderators:David Harpole, Tetsuya Mitsudomi
-
+
PL02.01 - Durvalumab ± Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase 3 POSEIDON Study
06:30 - 06:40 | Presenter: Melissa L Johnson
- Abstract
Loading... -
+
PL02.02 - Discussant
06:40 - 06:47 | Presenter: Julie Brahmer
- Abstract
No abstract available for this presentation
-
+
PL02.03 - Lurbinectedin/Doxorubicin versus CAV or Topotecan in Relapsed SCLC Patients: Phase III Randomized ATLANTIS Trial
06:47 - 06:57 | Presenter: Luis Paz-Ares
- Abstract
Loading... -
+
PL02.04 - Discussant
06:57 - 07:04 | Presenter: Charles M Rudin
- Abstract
No abstract available for this presentation
-
+
PL02.05 - IMpower010: Characterization of Stage IB-IIIA NSCLC Patients by Type and Extent of Therapy Prior to Adjuvant Atezolizumab
07:04 - 07:14 | Presenter: Nasser Altorki
- Abstract
Loading... -
+
PL02.06 - Discussant
07:14 - 07:21 | Presenter: Ichiro Yoshino
- Abstract
No abstract available for this presentation
-
+
PL02.07 - Global Variability in Lung Cancer Deaths Attributable to Air Pollution
07:21 - 07:31 | Presenter: Christine Dorothy Berg
- Abstract
Loading... -
+
PL02.08 - Discussant
07:31 - 07:38 | Presenter: Joachim G.J.V. Aerts
- Abstract
No abstract available for this presentation
-
+
PL02.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials
07:38 - 07:48 | Presenter: Matthew Smeltzer
- Abstract
Loading... -
+
PL02.10 - Discussant
07:48 - 07:55 | Presenter: Marina Chiara Garassino
- Abstract
No abstract available for this presentation
-
+
PL02.11 - Live Discussion with Speakers
07:55 - 08:00
- Abstract
No abstract available for this presentation
-
+
MA05 - Using Real World and Patient Reported Data to Identify Gaps and Needs for People with Lung Cancer: Impacts of the COVID-19 Pandemic, Treatment Patterns, and Psychosocial Impacts
- 08:15 - 09:15
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Patient Advocacy
-
+
MA05.01 - Patients’ Experiences During COVID-19: Insights from The Second Global Lung Cancer Coalition Patient Experience Survey
08:15 - 08:20 | Presenter: Jackie Fenemore
- Abstract
Loading... -
+
MA05.02 - Impact of COVID-19 on Lung Cancer Care and Utilization of Patient Support Resources
08:20 - 08:25 | Presenter: Rashmi Acharya
- Abstract
Loading... -
+
MA05.03 - Considering the Continued Impact of the COVID-19 Pandemic on Patient Advocacy and Support Organisations
08:25 - 08:30 | Presenter: Matthew Peters
- Abstract
Loading... -
+
MA05.04 - Discussant
08:30 - 08:45 | Presenter: Anne-Marie Baird
- Abstract
No abstract available for this presentation
-
+
MA05.05 - Treatment Patterns in Patients With EGFR-Positive Lung Cancer: A Real-World Patient-Report
08:45 - 08:50 | Presenter: Ivy B. Elkins
- Abstract
Loading... -
+
MA05.06 - The Psychosocial Impact of Lung Cancer – A European Perspective
08:50 - 08:55 | Presenter: Anne-Marie Baird
- Abstract
Loading... -
+
MA05.07 - Discussant
08:55 - 09:10 | Presenter: Jennifer C. King
- Abstract
No abstract available for this presentation
-
+
OA06 - Prognosis and Staging
- 08:15 - 09:15
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Staging/Pulmonary Medicine
- Moderators:Ann Leung
-
+
OA06.01 - Validation of the 8th Ed TNM: Invasive Size for Pathologic T Descriptor in Stage I-IIA Resected Nonmucinous Adenocarcinomas
08:15 - 08:25 | Presenter: Yan Li
- Abstract
Loading... -
+
OA06.02 - High-Grade Patterns Cause the Upstaging of Lung Adenocarcinomas From T1 to T2a: A Multicentric Analysis
08:25 - 08:35 | Presenter: Pietro Bertoglio
- Abstract
Loading... -
+
OA06.03 - PL1/2 Status is Associated With Worse Survival in T2 Non-Small Cell Lung Carcinoma: Is There A Need for a New Subgroup in the T Classification?
08:35 - 08:45 | Presenter: Ismail Sarbay
- Abstract
Loading... -
+
OA06.04 - Constructing a Global Molecular Database for Thoracic Malignancies: The IASLC Molecular Subcommittee Lung Cancer Dataset
08:45 - 08:55 | Presenter: Raymond Uyiosa Osarogiagbon
- Abstract
Loading... -
+
OA06.05 - Discussant
08:55 - 09:05 | Presenter: Jorge Alatorre
- Abstract
No abstract available for this presentation
-
+
OA06.06 - Live Discussion with Speakers
09:05 - 09:15
- Abstract
No abstract available for this presentation
-
+
OA07 - What's On The Horizon for SCLC?
- 08:15 - 09:15
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Oral
- Track: Small Cell Lung Cancer/ NET
- Moderators:Christine M. Lovly
-
+
OA07.01 - Signatures of Plasticity and Immunosuppression in a Single-Cell Atlas of Human Small Cell Lung Cancer
08:15 - 08:25 | Presenter: Joseph Minhow Chan
- Abstract
Loading... -
+
OA07.02 - TAZ Regulates SCLC Phenotypic Transition and Metastasis
08:25 - 08:35 | Presenter: Yujuan Jin
- Abstract
Loading... -
+
OA07.03 - A Phase II Study of Frontline Rucaparib + Nivolumab in Platinum Sensitive ES SCLC: Interim Analysis
08:35 - 08:45 | Presenter: Aman Chauhan
- Abstract
Loading... -
+
OA07.04 - Discussant
08:45 - 08:55 | Presenter: Anne Chiang
- Abstract
No abstract available for this presentation
-
+
OA07.05 - Live Discussion with Speakers
08:55 - 09:15
- Abstract
No abstract available for this presentation
-
+
MA06 - Differentiating Outcomes and Impact in Unresectable NSCLC
- 09:30 - 10:30
- 9/09/2021
- Location: Program Auditorium
- IASLC CME Accredited
- Type: Mini Oral
- Track: Locally Advanced Non-Small Cell Lung Cancer
-
+
MA06.01 - Death From Intercurrent Disease After Proton- Versus Photon-Based Chemoradiotherapy for Non-Small Cell Lung Cancer
09:30 - 09:35 | Presenter: Nikhil Yegya-Raman
- Abstract
Loading... -
+
MA06.02 - Impact of Heart and Lung Radiation Dose and Lymphopenia on Non-Small Cell Lung Cancer Outcomes
09:35 - 09:40 | Presenter: Jessica Little
- Abstract
Loading... -
+
MA06.03 - Deep Learning-Based Survival Prediction for Non-Small Cell Lung Cancer Patients Undergoing Radical Radiotherapy
09:40 - 09:45 | Presenter: Bilal Tahir
- Abstract
Loading... -
+
MA06.04 - Discussant
09:45 - 10:00 | Presenter: Megan Daly
- Abstract
No abstract available for this presentation
-
+
MA06.05 - Patterns of Care in Maintenance Therapy in U.S. Patients Undergoing Definitive Chemoradiation for Stage 3 Non-Small Cell Lung Cancer (NCSLC)
10:00 - 10:05 | Presenter: Jason Liu
- Abstract
Loading... -
+
MA06.06 - Treatment Recommendations for Stage III NSCLC by 3 Dutch Multidisciplinary Tumor Boards Prior To, and Following the PACIFIC Trial
10:05 - 10:10 | Presenter: Merle I. Ronden
- Abstract
Loading... -
+
MA06.07 - Inferior Outcomes in Minority Patients with Unresectable Non-Small Cell Lung Cancer (NSCLC) After Durvalumab Consolidation Therapy
10:10 - 10:15 | Presenter: Franco Adjei-Baffour Dickson
- Abstract
Loading... -
+
MA06.08 - Discussant
10:15 - 10:30 | Presenter: Jyoti Patel
- Abstract
No abstract available for this presentation
first
prev
